Cargando…

781. Non-Tuberculous Mycobacterium: Often a Missed Entity

BACKGROUND: Initially referred to as Lady Windermere syndrome, the prevalence of Non-Tuberculous Mycobacterium (NTM) is on the rise globally. In India, the TB capital of the world, these infections still go unrecognized, as the clinical presentation of all mycobacterial diseases are similar. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: B, Sairam, Gogia, Atul, Kakar, Atul, Byotra, S P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253252/
http://dx.doi.org/10.1093/ofid/ofy210.788
_version_ 1783373455136129024
author B, Sairam
Gogia, Atul
Kakar, Atul
Byotra, S P
author_facet B, Sairam
Gogia, Atul
Kakar, Atul
Byotra, S P
author_sort B, Sairam
collection PubMed
description BACKGROUND: Initially referred to as Lady Windermere syndrome, the prevalence of Non-Tuberculous Mycobacterium (NTM) is on the rise globally. In India, the TB capital of the world, these infections still go unrecognized, as the clinical presentation of all mycobacterial diseases are similar. This is of clinical relevance as misdiagnosis may lead to unwarranted or inappropriate therapy. METHODS: We conducted a retrospective study of adults suspected of having mycobacterial infection. Records of patients admitted with suspected TB from January 2015 to December 2017 were reviewed; clinicoradiological features were correlated with the organism isolated; treatment given and outcomes were recorded. RESULTS: Out of 877 suspected patients, 245 patients had microbiologically proven Mycobacterium tuberculosis and 34 had NTM (3.8%). Pulmonary infection was seen in 19 cases (56%), rest were extra pulmonary (34%). Fever was the commonest symptom (62%) others being cough (50%), breathlessness (41%), hemoptysis (15%), weight loss (3%), chest pain (3%), and back ache (12%). Symptoms were prolonged (>1 month) in 65% of cases. Radiologically, cavitations (42%), lung nodules (32%), and infiltrates (32%) were commonly seen. Upper zone predilection was noted in 68% of cases. Past tuberculosis was the major risk factor seen in 42% of cases while 26% were immunocompromised. Macrolide resistance was noted in none of our patients. Twenty-four out of 34 cases were AFB smear positive (71%), but MTB gene Xpert was negative. Our series includes four patients who did not respond to first-line anti-tubercular therapy (ATT) and were suspected to have multi-drug-resistant (MDR) tuberculosis. Cultures later grew NTM and the patients improved with macrolide regime. CONCLUSION: NTM is an underreported infection in a developing country like India with a high TB prevalence. Similar clinical features and morphology create a greater diagnostic dilemma. Usage of molecular techniques and AFB culture should be made mandatory in all suspected cases of tuberculosis. NTM should always be considered in ATT nonresponders before starting them on MDR regime. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253252
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62532522018-11-28 781. Non-Tuberculous Mycobacterium: Often a Missed Entity B, Sairam Gogia, Atul Kakar, Atul Byotra, S P Open Forum Infect Dis Abstracts BACKGROUND: Initially referred to as Lady Windermere syndrome, the prevalence of Non-Tuberculous Mycobacterium (NTM) is on the rise globally. In India, the TB capital of the world, these infections still go unrecognized, as the clinical presentation of all mycobacterial diseases are similar. This is of clinical relevance as misdiagnosis may lead to unwarranted or inappropriate therapy. METHODS: We conducted a retrospective study of adults suspected of having mycobacterial infection. Records of patients admitted with suspected TB from January 2015 to December 2017 were reviewed; clinicoradiological features were correlated with the organism isolated; treatment given and outcomes were recorded. RESULTS: Out of 877 suspected patients, 245 patients had microbiologically proven Mycobacterium tuberculosis and 34 had NTM (3.8%). Pulmonary infection was seen in 19 cases (56%), rest were extra pulmonary (34%). Fever was the commonest symptom (62%) others being cough (50%), breathlessness (41%), hemoptysis (15%), weight loss (3%), chest pain (3%), and back ache (12%). Symptoms were prolonged (>1 month) in 65% of cases. Radiologically, cavitations (42%), lung nodules (32%), and infiltrates (32%) were commonly seen. Upper zone predilection was noted in 68% of cases. Past tuberculosis was the major risk factor seen in 42% of cases while 26% were immunocompromised. Macrolide resistance was noted in none of our patients. Twenty-four out of 34 cases were AFB smear positive (71%), but MTB gene Xpert was negative. Our series includes four patients who did not respond to first-line anti-tubercular therapy (ATT) and were suspected to have multi-drug-resistant (MDR) tuberculosis. Cultures later grew NTM and the patients improved with macrolide regime. CONCLUSION: NTM is an underreported infection in a developing country like India with a high TB prevalence. Similar clinical features and morphology create a greater diagnostic dilemma. Usage of molecular techniques and AFB culture should be made mandatory in all suspected cases of tuberculosis. NTM should always be considered in ATT nonresponders before starting them on MDR regime. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253252/ http://dx.doi.org/10.1093/ofid/ofy210.788 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
B, Sairam
Gogia, Atul
Kakar, Atul
Byotra, S P
781. Non-Tuberculous Mycobacterium: Often a Missed Entity
title 781. Non-Tuberculous Mycobacterium: Often a Missed Entity
title_full 781. Non-Tuberculous Mycobacterium: Often a Missed Entity
title_fullStr 781. Non-Tuberculous Mycobacterium: Often a Missed Entity
title_full_unstemmed 781. Non-Tuberculous Mycobacterium: Often a Missed Entity
title_short 781. Non-Tuberculous Mycobacterium: Often a Missed Entity
title_sort 781. non-tuberculous mycobacterium: often a missed entity
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253252/
http://dx.doi.org/10.1093/ofid/ofy210.788
work_keys_str_mv AT bsairam 781nontuberculousmycobacteriumoftenamissedentity
AT gogiaatul 781nontuberculousmycobacteriumoftenamissedentity
AT kakaratul 781nontuberculousmycobacteriumoftenamissedentity
AT byotrasp 781nontuberculousmycobacteriumoftenamissedentity